HIGHLIGHTS
- who: Joseph Pergolizzi and colleagues from the Gu00e4vleborg/Uppsala University, Gu00e4vle, Medicine, Cardiology Research Unit, Karolinska Institutet, Stockholm have published the article: Received 01/06/2022 Review began 02/07/2022 Review ended 05/16/2022 Published 06/16/2022, in the Journal: (JOURNAL) of June/16,/2022
- what: The aim of this narrative review is to evaluate recent studies of these agents and whether these agents may be considered safe, effective pain relievers in the population of chronic cancer and non-cancer pain patients, for whom there are often no ideal analgesic agents. This . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.